BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21887275)

  • 1. Insulin receptor tyrosine kinase substrate enhances low levels of MDM2-mediated p53 ubiquitination.
    Wang KS; Chen G; Shen HL; Li TT; Chen F; Wang QW; Wang ZQ; Han ZG; Zhang X
    PLoS One; 2011; 6(8):e23571. PubMed ID: 21887275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
    Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation.
    Fu W; Ma Q; Chen L; Li P; Zhang M; Ramamoorthy S; Nawaz Z; Shimojima T; Wang H; Yang Y; Shen Z; Zhang Y; Zhang X; Nicosia SV; Zhang Y; Pledger JW; Chen J; Bai W
    J Biol Chem; 2009 May; 284(21):13987-4000. PubMed ID: 19321440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRTKS is correlated with progression and survival time of patients with gastric cancer.
    Huang LY; Wang X; Cui XF; Li H; Zhao J; Wu CC; Min L; Zhou Z; Wan L; Wang YP; Zhang C; Gao WQ; Sun Y; Han ZG
    Gut; 2018 Aug; 67(8):1400-1409. PubMed ID: 28647685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
    Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
    Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.
    Wang L; He G; Zhang P; Wang X; Jiang M; Yu L
    Mol Biol Rep; 2011 Jan; 38(1):229-36. PubMed ID: 20333547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity.
    Ranaweera RS; Yang X
    J Biol Chem; 2013 Jun; 288(26):18939-46. PubMed ID: 23671280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.
    Saville MK; Sparks A; Xirodimas DP; Wardrop J; Stevenson LF; Bourdon JC; Woods YL; Lane DP
    J Biol Chem; 2004 Oct; 279(40):42169-81. PubMed ID: 15280377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
    Nie J; Xie P; Liu L; Xing G; Chang Z; Yin Y; Tian C; He F; Zhang L
    J Biol Chem; 2010 Jul; 285(30):22818-30. PubMed ID: 20484049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP.
    Ali A; Farooqui SR; Rai J; Singh J; Kumar V; Mishra R; Banerjea AC
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1038-1044. PubMed ID: 32819562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.
    Zhao K; Yang Y; Zhang G; Wang C; Wang D; Wu M; Mei Y
    EMBO Rep; 2018 Feb; 19(2):305-319. PubMed ID: 29295817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
    Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
    Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation.
    Wu H; Leng RP
    Cell Cycle; 2011 Jun; 10(12):1912-5. PubMed ID: 21558803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway.
    Xu L; Hu J; Zhao Y; Hu J; Xiao J; Wang Y; Ma D; Chen Y
    Apoptosis; 2012 Nov; 17(11):1235-45. PubMed ID: 22914926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
    Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
    Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ubiquitination in the direct mitochondrial death program of p53.
    Marchenko ND; Moll UM
    Cell Cycle; 2007 Jul; 6(14):1718-23. PubMed ID: 17630506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSL2 promotes Mdm2-independent cytoplasmic localization of p53.
    Kruse JP; Gu W
    J Biol Chem; 2009 Jan; 284(5):3250-3263. PubMed ID: 19033443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.
    Zhang X; Wang W; Wang H; Wang MH; Xu W; Zhang R
    Oncogene; 2013 May; 32(22):2782-91. PubMed ID: 22777350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2-Driven Ubiquitination Rapidly Removes p53 from Its Cognate Promoters.
    Henningsen KM; Manzini V; Magerhans A; Gerber S; Dobbelstein M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.